Evidence map›Paper›PMID 25189349›Full record

ReviewThe Lancet. Infectious diseases2014

Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections--needs, advances, and future prospects.

Alimuddin Zumla, Jaffar A Al-Tawfiq, Virve I Enne, Mike Kidd, Christian Drosten, Judy Breuer, Marcel A Muller, David Hui, Markus Maeurer, Matthew Bates and 7 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in The Lancet. Infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05864118 (A Comparative Evaluation of Specimen Adequacy of a Traditional Nasopharyngeal Swab as Compared to Nasopharyngeal Saline Wash, Saliva, and Serum to Test for Respiratory Viruses and Antibody Response), which is not on this map. Cited by 84 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 4 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05864118 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

A Comparative Evaluation of Specimen Adequacy of a Traditional Nasopharyngeal Swab as Compared to Nasopharyngeal Saline Wash, Saliva, and Serum to Test for Respiratory Viruses and Antibody Response

TypeinterventionalSponsorUniversity of NebraskaRan2023 to 2027Enrolled1,000ConditionsRespiratory Tract InfectionsArmsRespiratory pathogen panel PCR test, COVID-19 antibody test
3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 4 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Fluorescent optotracers for bacterial and biofilm detection and diagnostics.Science and technology of advanced materials · 2023
    Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 8 countries.

Alimuddin ZumlaDivision of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Center, University College London Hospitals, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Foundation Trust, London, UK; Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Kingdom of Saudi Arabia; UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: a.zumla@ucl.ac.uk.
Jaffar A Al-TawfiqJohn Hopkins Aramco healthcare, Dahran, Saudi Arabia.
Virve I EnneDivision of Infection and Immunity, University College London, London, UK.
Mike KiddDivision of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Foundation Trust, London, UK.
Christian DrostenInstitute of Virology, University of Bonn Medical Centre, Bonn, Germany.
Judy BreuerDivision of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Center, University College London Hospitals, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Foundation Trust, London, UK.
Marcel A MullerInstitute of Virology, University of Bonn Medical Centre, Bonn, Germany.
David HuiDivision of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong.
Markus MaeurerTherapeutic Immunology, Departments of Laboratory Medicine and Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Matthew BatesDivision of Infection and Immunity, University College London, London, UK; UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
Peter MwabaUNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
Rafaat Al-HakeemGlobal Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Gregory GrayDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.
Philippe GautretAssistance Publique Hôpitaux de Marseille, CHU Nord, Pôle Infectieux, Institut Hospitalo-Universitaire Méditerranée Infection & Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), Marseille, France.
Abdullah A Al-RabeeahGlobal Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Ziad A MemishGlobal Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Kingdom of Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia.
Vanya GantDepartment of Medical Microbiology, University College London Hospitals NHS Foundation Trust, London, UK.
Ministry of Health · SAUniversity College London · GBUniversity of Bonn · DEChinese University of Hong Kong · CNKarolinska Institutet · SESaudi Aramco Medical Services Organization · SAUCL Biomedical Research Centre · GBUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes · FRUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Florida · USUniversity of Zambia · ZMUniversity Teaching Hospital · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory tract infections rank second as causes of adult and paediatric morbidity and mortality worldwide. Respiratory tract infections are caused by many different bacteria (including mycobacteria) and viruses, and rapid detection of pathogens in individual cases is crucial in achieving the best clinical management, public health surveillance, and control outcomes. Further challenges in improving management outcomes for respiratory tract infections exist: rapid identification of drug resistant pathogens; more widespread surveillance of infections, locally and internationally; and global responses to infections with pandemic potential. Developments in genome amplification have led to the discovery of several new respiratory pathogens, and sensitive PCR methods for the diagnostic work-up of these are available. Advances in technology have allowed for development of single and multiplexed PCR techniques that provide rapid detection of respiratory viruses in clinical specimens. Microarray-based multiplexing and nucleic-acid-based deep-sequencing methods allow simultaneous detection of pathogen nucleic acid and multiple antibiotic resistance, providing further hope in revolutionising rapid point of care respiratory tract infection diagnostics.

Indexed as

Bacterial InfectionsHumansMolecular Diagnostic TechniquesPoint-of-Care SystemsRespiratory Tract InfectionsVirus Diseases

Identifiers

PMID25189349
PMCPMC7106435
OpenAlexW2015464721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.